Skip to main content
. 2020 Apr 15;20(1):346–356. doi: 10.3892/ol.2020.11536

Figure 4.

Figure 4.

Effects of co-treatment with gemcitabine and sorafenib on migration of A549 cells. (A) A549 cells were treated with a combination of 10 µg/ml gemcitabine and 10 µM sorafenib for 48 h, and cell migration was determined by a wound healing assay using an inverted microscope (magnification, ×200). (B) Quantification of A549 migratory cells. *P<0.05 vs. gemcitabine group; **P<0.01 vs. gemcitabine group; #P<0.05 vs. sorafenib group; ##P<0.01 vs. sorafenib group.